Drug Induced Psychosis Quotes

The psychosis-inducing effects of synthetics offered one last, crucial piece of evidence about the risks of cannabis. And so, in January 2017, the National Academy of Medicine examined the thirty years of research that had begun with Sven Andréasson’s paper and declared the issue settled. “The association between cannabis use and development of a psychotic disorder is supported by data synthesized in several good-quality systematic reviews,” the NAM wrote. “The magnitude of this association is moderate to large and appears to be dose-dependent . . . The primary literature reviewed by the committee confirms the conclusions of the systematic reviews.” But almost no one noticed the National Academy report. The New York Times published an online summary of its findings—in May 2018, more than a year after it appeared. It has not changed the public policy debate around marijuana in the United States or perceptions of the safety of the drug.